Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE RISSOUANT : revenue, balance sheet and financial ratios

SELARL PHARMACIE RISSOUANT is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ABONDANCE (74360), this company of category PME shows in 2025 a net income positive of 90 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE RISSOUANT (SIREN 844925420)
Indicator 2025 2024 2021 2020
Revenue N/C N/C N/C N/C
Net income 89 981 € 84 931 € 103 164 € 41 509 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE RISSOUANT generates positive net income of 90 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 42 k€ -> 90 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

89 981 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 33%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

32.755%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

72.264%

Solvency indicators evolution
SELARL PHARMACIE RISSOUANT

Sector positioning

Debt ratio
32.76 2025
2021
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good -37 pts over 3 years

In 2025, the debt ratio of SELARL PHARMACIE RISSOUANT (32.76) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
72.26% 2025
2021
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent +50 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE RISSOUANT (72.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 172.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

172.452

Liquidity indicators evolution
SELARL PHARMACIE RISSOUANT

Sector positioning

Liquidity ratio
172.45 2025
2021
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average -18 pts over 3 years

In 2025, the liquidity ratio of SELARL PHARMACIE RISSOUANT (172.45) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELARL PHARMACIE RISSOUANT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE RISSOUANT is estimated at 1 429 358 € (range 969 969€ - 2 242 860€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
969k€ 1429k€ 2242k€
1 429 358 € Range: 969 969€ - 2 242 860€
NAF 5 année 2025

Valuation method used

Net Income Multiple
89 981 € × 15.9x = 1 429 359 €
Range: 969 970€ - 2 242 861€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE RISSOUANT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE RISSOUANT

What is the revenue of SELARL PHARMACIE RISSOUANT ?

The revenue of SELARL PHARMACIE RISSOUANT is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE RISSOUANT profitable?

Yes, SELARL PHARMACIE RISSOUANT generated a net profit of 90 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE RISSOUANT ?

The headquarters of SELARL PHARMACIE RISSOUANT is located in ABONDANCE (74360), in the department Haute-Savoie.

Where to find the tax return of SELARL PHARMACIE RISSOUANT ?

The tax return of SELARL PHARMACIE RISSOUANT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE RISSOUANT operate?

SELARL PHARMACIE RISSOUANT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.